No Data
No Data
Wall Street Rallies As Economic Concerns Recede, Tech Flexes Its Muscles, Semiconductors Soar: What's Driving Markets Thursday?
Jobless Claims Decline, Pre-Markets in the Green
Gilead Sciences Q2 24 Earnings Conference Call At 4:30 PM ET
Warner Bros. Discovery, Robinhood, Bumble, Fastly, Zillow, Duolingo, Eli Lilly, and More Stock Market Movers
Guolian Securities: Increased attention to tumor immunology, recommend focusing on targeted drugs such as PD1/IL2 in pharmaceutical companies.
With the increasing attention to tumor immunity, and the successive launch of advantageous products, bullish on PD1/IL2 and PD1/IL15 targeted drugs.
Gilead Sciences Q2 Earnings Preview: Focus on CAR-T Market and Oncology
No Data